3D Bioprinting Market 2022 - Industry Analysis, Size, Share, Strategies and Forecast to 2027

3D bioprinting is a rapidly emerging technology that has the potential to revolutionize medical treatments. This technology uses 3D printing technology to create biological structures, such as organs and tissues, that can be transplanted into the body. With 3D bioprinting, organs and tissues can be designed and printed with precision, allowing for the creation of custom-made solutions for individual patients. In the near future, 3D bioprinting could be used to create artificial organs, tissues, and even pharmaceuticals. With the potential to reduce the need for organ donors and provide personalized treatments, 3D bioprinting is poised to revolutionize the medical field.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170201787&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

3D Bioprinting market in terms of revenue was estimated to be worth $1.3 billion in 2022 and is poised to reach $3.3 billion by 2027, growing at a CAGR of 20.8% from 2022 to 2027 according to a latest report published by MarketsandMarkets™. Factors such as technological advancements in 3D bioprinters and biomaterials, increasing use of 3D bioprinting in the pharmaceutical and cosmetology industries, and rising public and private funding to support bioprinting research activities drive the market growth. However, factors like dearth of skilled professionals and high development and production costs are restraining the growth of this market.

Notable 3D Bioprinting mergers and acquisitions for 2021 - 2022 include:

HP's Acquisition of Cells on Chips: In February 2021, HP Inc. announced the acquisition of Cells on Chips, a bioprinting company that produces 3D bioprinted tissue models for drug discovery and development.

Canon BioMedical's Acquisition of BioBots: In April 2021, Canon BioMedical announced the acquisition of BioBots, a bioprinting company that produces automated 3D bioprinting platforms and biomaterials for scientific research and medical applications.

Stratasys' Acquisition of Origin: In April 2021, Stratasys announced the acquisition of Origin, a 3D bioprinting startup focused on developing automated systems for bioprinting complex tissue constructs.

Growth Drivers of 3D Bioprinting Market from macro to micro:

Macro Level:

1. Increasing demand for personalized and customized medical devices: The demand for personalized and customized medical devices is increasing due to the growing demand for personalized healthcare solutions. This is driving the growth of the 3D bioprinting market.

2. Technological advancements in 3D printing technologies: The advancements in 3D printing technologies have enabled the production of more complex and accurate 3D printed biological structures. This is driving the growth of the 3D bioprinting market.

3. Government initiatives and investments to promote 3D bioprinting: Governments across the globe are promoting 3D bioprinting through investments and grants. This is driving the growth of the 3D bioprinting market.

Micro Level:

1. Growing adoption of 3D bioprinting in organ transplantation and regenerative medicine: The rising demand for organ transplantation and regenerative medicine is driving the growth of the 3D bioprinting market.

2. Growing demand for 3D bioprinting in drug discovery and development: The increasing demand for 3D bioprinting in drug discovery and development is driving the growth of the 3D bioprinting market.

3. Growing demand for 3D bioprinting in tissue engineering and research: The growing demand for 3D bioprinting in tissue engineering and research is driving the growth of the 3D bioprinting market.

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=170201787&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

Top 3 use cases of 3D Bioprinting market:

1. Tissue Engineering: 3D bioprinting has been used in tissue engineering applications to create 3D structures from living cells. The 3D bioprinting process enables researchers to create 3D structures of various shapes, sizes and textures, and then populate them with cells that are then allowed to grow and develop into the desired tissue or organ.

2. Pharmaceuticals: 3D bioprinting has been used in pharmaceutical research to create 3D structures for drug testing. The 3D structures are created with living cells, so they can be used to test the efficacy of drugs or to see how certain drugs interact with different cells.

3. Medical Implants: 3D bioprinting has also been used in the development of medical implants. Using living cells and biocompatible materials, 3D bioprinting can be used to create custom implants that can be used to replace damaged parts of the body. This could have a huge impact on the medical world, as it could allow for more personalized medical treatments.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=170201787&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.